Related Experiment Video
Updated: Jun 24, 2025

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
Published on: April 13, 2015
The TERT Promoter is Polycomb-Repressed in Neuroblastoma Cells with Long Telomeres
Mindy K Graham1,2, Beisi Xu3, Christine Davis4
1Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Epigenetic regulation of telomerase (TERT) differs in neuroblastoma based on telomere maintenance. H3K27 methylation represses TERT in long-telomere neuroblastoma, while MYCN drives TERT in short-telomere cases.
Area of Science:
- Oncology
- Epigenetics
- Cancer Biology
Background:
- Neuroblastoma, a high-risk cancer, often maintains telomeres via telomerase (TERT) or alternative lengthening of telomeres (ALT).
- A subset of neuroblastoma exhibits long telomeres without a clear telomere maintenance mechanism, suggesting alternative regulatory pathways.
- The epigenetic regulation of the TERT locus in neuroblastoma remains incompletely understood, particularly in cases with distinct telomere lengths and maintenance statuses.
Purpose of the Study:
- To investigate the epigenetic mechanisms governing telomerase (TERT) expression in neuroblastoma with varying telomere lengths and maintenance statuses.
- To elucidate the role of DNA methylation and histone modifications, specifically H3K27 trimethylation (H3K27me3), in regulating TERT expression.
- To determine the influence of MYCN oncogene binding and Polycomb Repressive Complex 2 (PRC2) activity on TERT locus regulation.
Main Methods:
- Analysis of TERT promoter and locus DNA methylation patterns across neuroblastoma subtypes.
- Chromatin immunoprecipitation (ChIP) to assess active and repressive histone marks (e.g., H3K27me3) at the TERT locus.
- Investigation of MYCN binding to the TERT promoter using ChIP assays.
- Pharmacological inhibition of EZH2, a key component of PRC2, to assess its impact on TERT expression and MYCN binding.
Main Results:
- Neuroblastoma exhibits broad TERT promoter hypomethylation, distinct from most cancers.
- Telomerase-positive neuroblastoma shows active chromatin at TERT with MYCN-driven expression.
- Neuroblastoma with long telomeres displays widespread H3K27me3 enrichment across the TERT locus and nearby genes, alongside subtelomeric repressive marks.
- EZH2 inhibition reactivates TERT expression in long-telomere neuroblastoma cells and facilitates MYCN binding to the TERT promoter.
Conclusions:
- Epigenetic regulation of TERT expression is heterogeneous in neuroblastoma, correlating with telomere length and maintenance mechanisms.
- H3K27 methylation by PRC2 plays a critical role in repressing TERT expression in neuroblastoma with long telomeres.
- Targeting EZH2 may offer a therapeutic strategy to reactivate TERT in specific neuroblastoma subtypes.
More Related Videos
09:13Generation of Cancer Cell Clones to Visualize Telomeric Repeat-containing RNA TERRA Expressed from a Single Telomere in Living Cells
Published on: January 17, 2019
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Related Concept Videos
Replicative Cell Senescence
Telomeres and Telomerase
Abnormal Proliferation
Negative Regulator Molecules
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Epigenetic Regulation
X-chromosome...